Literature DB >> 34338744

Does gut microbiota affect atrial rhythm? Causalities and speculations.

Dominik Linz1,2,3,4, Monika Gawałko1,2,5,6, Prashanthan Sanders3, John Penders7, Na Li8, Stanley Nattel6,9,10, Dobromir Dobrev6,9,11.   

Abstract

Dietary intake has been shown to change the composition of gut microbiota and some changes in microbiota (dysbiosis) have been linked to diabetes, hypertension, and obesity, which are established risk factors for atrial fibrillation (AF). In addition, intestinal dysbiosis generates microbiota-derived bioactive metabolites that might exert proarrhythmic actions. Although emerging preclinical investigations and clinical observational cohort studies suggest a possible role of gut dysbiosis in AF promotion, the exact mechanisms through which dysbiosis contributes to AF remain unclear. This Viewpoint article briefly reviews evidence suggesting that abnormalities in the intestinal microbiota play an important and little-recognized role in the pathophysiology of AF and that an improved understanding of this role may open up new possibilities in the management of AF. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Arrhythmia; Atrial fibrillation; cardiometabolic; dysbiosis; gut microbiota; metabolites

Mesh:

Year:  2021        PMID: 34338744      PMCID: PMC8442110          DOI: 10.1093/eurheartj/ehab467

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   35.855


  15 in total

1.  Microbiome and atrial fibrillation.

Authors:  Ricardo Sadashi Mishima; Adrian D Elliott; Prashanthan Sanders; Dominik Linz
Journal:  Int J Cardiol       Date:  2018-03-15       Impact factor: 4.164

Review 2.  Gut Microbiota in Cardiovascular Health and Disease.

Authors:  W H Wilson Tang; Takeshi Kitai; Stanley L Hazen
Journal:  Circ Res       Date:  2017-03-31       Impact factor: 17.367

Review 3.  Beyond gut feelings: how the gut microbiota regulates blood pressure.

Authors:  Francine Z Marques; Charles R Mackay; David M Kaye
Journal:  Nat Rev Cardiol       Date:  2017-08-24       Impact factor: 32.419

4.  Circulating primary bile acid is correlated with structural remodeling in atrial fibrillation.

Authors:  Xin-Hua Wang; Zheng Li; Min-Hua Zang; Tian-Bao Yao; Jia-Liang Mao; Jun Pu
Journal:  J Interv Card Electrophysiol       Date:  2019-03-26       Impact factor: 1.900

5.  The uremic toxin indoxyl sulfate increases pulmonary vein and atrial arrhythmogenesis.

Authors:  Wei-Ta Chen; Yao-Chang Chen; Ming-Hsiung Hsieh; Shih-Yu Huang; Yu-Hsun Kao; Yi-Ann Chen; Yung-Kuo Lin; Shih-Ann Chen; Yi-Jen Chen
Journal:  J Cardiovasc Electrophysiol       Date:  2014-11-04

6.  Trimethyllysine, a trimethylamine N-oxide precursor, provides near- and long-term prognostic value in patients presenting with acute coronary syndromes.

Authors:  Xinmin S Li; Slayman Obeid; Zeneng Wang; Benjamin J Hazen; Lin Li; Yuping Wu; Alex G Hurd; Xiaodong Gu; Alan Pratt; Bruce S Levison; Yoon-Mi Chung; Steven E Nissen; Wai Hong Wilson Tang; François Mach; Lorenz Räber; David Nanchen; Christian M Matter; Thomas F Lüscher; Stanley L Hazen
Journal:  Eur Heart J       Date:  2019-08-21       Impact factor: 29.983

7.  Gut-Derived Serum Lipopolysaccharide is Associated With Enhanced Risk of Major Adverse Cardiovascular Events in Atrial Fibrillation: Effect of Adherence to Mediterranean Diet.

Authors:  Daniele Pastori; Roberto Carnevale; Cristina Nocella; Marta Novo; Maria Santulli; Vittoria Cammisotto; Danilo Menichelli; Pasquale Pignatelli; Francesco Violi
Journal:  J Am Heart Assoc       Date:  2017-06-05       Impact factor: 5.501

8.  Indoxyl Sulphate is Associated with Atrial Fibrillation Recurrence after Catheter Ablation.

Authors:  Fumi Yamagami; Kazuko Tajiri; Kosuke Doki; Masayuki Hattori; Junya Honda; Satoshi Aita; Tomohiko Harunari; Hiro Yamasaki; Nobuyuki Murakoshi; Yukio Sekiguchi; Masato Homma; Naohiko Takahashi; Kazutaka Aonuma; Akihiko Nogami; Masaki Ieda
Journal:  Sci Rep       Date:  2018-11-22       Impact factor: 4.379

9.  Trimethylamine N-oxide in atrial fibrillation progression.

Authors:  Petra Büttner; Jürgen G Okun; Jana Hauke; Erik Holzwirth; Danilo Obradovic; Gerhard Hindricks; Holger Thiele; Jelena Kornej
Journal:  Int J Cardiol Heart Vasc       Date:  2020-06-11

10.  Pharmacological inhibition of sodium-proton-exchanger subtype 3-mediated sodium absorption in the gut reduces atrial fibrillation susceptibility in obese spontaneously hypertensive rats.

Authors:  Benedikt Linz; Mathias Hohl; Ricardo Mishima; Arnela Saljic; Dennis H Lau; Thomas Jespersen; Ulrich Schotten; Prashanthan Sanders; Dominik Linz
Journal:  Int J Cardiol Heart Vasc       Date:  2020-05-20
View more
  2 in total

1.  Commensal microbe-derived SCFA alleviates atrial fibrillation via GPR43/NLRP3 signaling.

Authors:  Kun Zuo; Chen Fang; Zheng Liu; Yuan Fu; Ye Liu; Lifeng Liu; Yuxing Wang; Xiandong Yin; Xiaoqing Liu; Jing Li; Jiuchang Zhong; Mulei Chen; Li Xu; Xinchun Yang
Journal:  Int J Biol Sci       Date:  2022-06-27       Impact factor: 10.750

Review 2.  Mechanisms Underlying Antiarrhythmic Properties of Cardioprotective Agents Impacting Inflammation and Oxidative Stress.

Authors:  Katarina Andelova; Barbara Szeiffova Bacova; Matus Sykora; Peter Hlivak; Miroslav Barancik; Narcis Tribulova
Journal:  Int J Mol Sci       Date:  2022-01-26       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.